30 completed, 12 unknown, 4 recruiting, 1 active not recruiting. 28 Not applicable, 9 Phase 2, 3 Phase 4, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 28 | Completed 19, Unknown 5, Recruiting 3, Not yet recruiting 1 |
| Phase 2 | 9 | Completed 4, Unknown 4, Recruiting 1 |
| Phase 4 | 3 | Completed 2, Active not recruiting 1 |
| Phase 1 | 2 | Completed 2 |
Follow Howard University: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Solving Stigma Through POV Simulation: Enhancing Pharmacist Empathy-based Practices With Sickle Cell Disease Patients point of view simulation, Control - Stigma | Not applicable | Not yet recruiting | Ohio State University | 200 | 2026-09-01 | 2026-07-01 |
| BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis BRAVE (Behavioral Response Against Violence Engagement), Treatment As Usual (TAU) - Violence Risk, Early Psychosis | Not applicable | Recruiting | Howard University | 30 | 2026-07-02 | 2026-07-29 |
| Music for Pain and Dementia Drumming session, Music-listening session - Alzheimer Disease, Dementia | Not applicable | Recruiting | Yale University | 60 | 2026-06-09 | 2026-09-21 |
| Integrating MOUD in Nonmedical Community Settings (Better Together) HC-MOUD Only, BT-MOUD with Buprenorphine - Opioid Use Disorder | Not applicable | Recruiting | Howard University | 400 | 2026-04-15 | 2026-10-13 |
| Neurophysiological Benefits of Live Music for Early Alzheimer's Patients and Their Caregivers Pre-recorded Music Session, Live Music Session - Alzheimer Disease, Dementia | Not applicable | Completed | Yale University | 10 | 2025-01-28 | 2026-10-19 |
| Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P) Computerized Chemosensory-Based Orbitofrontal Cortex Training for Pain, Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) - Chronic Pain, Low Back Pain | Phase 2 | Recruiting | Evon Medics LLC | 220 | 2024-10-23 | 2024-11-04 |
| Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention Mind Over Matter (MOM) - Cancer, Breast Cancer | Completed | Inova Health Care Services | 40 | 2024-01-17 | 2025-02-27 | |
| Evaluating the Effectiveness of a Cognitive Behavioral Intervention (CBI) Cognitive behavioral intervention, Colgate smart toothbrush - Adolescent Behavior, Dental Plaque | Not applicable | Completed | Howard University | 150 | 2023-08-06 | 2025-04-29 |
| Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders EDITOR (CBOT with olfactory stimulants, OFC tasks & remote monitoring of treatment compliance), CBOT with olfactory stimulants & OFC tasks, CBOT Sham - Substance Use Disorders, Opioid Use Disorder | Phase 2 | Unknown | Evon Medics LLC | 300 | 2023-07-07 | 2024-05-30 |
| Preoperative Mindfulness: Minimally Invasive Hysterectomy Mindfulness training - Pain, Postoperative | Not applicable | Completed | Montefiore Medical Center | 72 | 2023-06-20 | 2026-01-23 |
| Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence Beta3-Agonists, Adrenergic [Mirabegron/Vibegron], OnabotulinumtoxinA 100 UNT [Botox] - Urgency Urinary Incontinence | Phase 4 | Active not recruiting | Women and Infants Hospital of Rhode Island | 432 | 2023-06-06 | 2026-06-29 |
| Development and Evaluation of Computerized Chemosensory Based Orbitofrontal Networks Training for Treatment of Pain Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) short burst paradigm, Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) long burst paradigm, Computerized Chemosensory-Based Orbitofrontal Cortex Training plus beta caryophyllene (CBOT-Plus) - Chronic Pain, Low Back Pain | Phase 1 | Completed | Evon Medics LLC | 86 | 2023-04-27 | 2024-01-23 |
| Social Risk Factors and Discrimination in Cancer Survivorship Community Health Worker support - Social Determinants of Health, Breast Cancer | Not applicable | Completed | Medstar Health Research Institute | 506 | 2022-05-05 | 2026-10-16 |
| Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease COT, Sham - Mild Cognitive Impairment, Early Alzheimer's Disease | Phase 2 | Unknown | Evon Medics LLC | 200 | 2021-11-15 | 2022-05-17 |
| Improving Treatment and Recovery Services for Individuals With Opioid Problems Recovery Guide Counseling - Counseling | Unknown | Howard University | 20 | 2021-10-15 | 2021-11-22 | |
| Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder CBOT + TAU, Sham + TAU - Opioid Use Disorder, Moderate, Opioid Use Disorder, Severe | Phase 2 | Unknown | Evon Medics LLC | 190 | 2021-03-26 | 2021-08-06 |
| Saffron as Anti Inflammatory Agent In Patients With Inflammatory Bowel Disease saffron supplement for IBD - Ulcerative Colitis | Not applicable | Unknown | Howard University | 100 | 2020-12-15 | 2021-02-11 |
| Improving Child Mental Health Service Utilization in Ibadan IUSECAMH Parent Intervention (Waitlist) - Mental Health Issue | Not applicable | Unknown | Howard University | 100 | 2020-12-01 | 2020-11-13 |
| The Provider Awareness and Cultural Dexterity Toolkit for Surgeons Trial PACTS curriculum, Standard Residency Curriculum - Resident Knowledge and Attitudes Regarding Cross-cultural Care, Interpersonal and Communication Skills in Patient-clinician Encounters | Not applicable | Completed | Brigham and Women's Hospital | 2901 | 2019-07-01 | 2024-06-07 |
| Pilot Trial of Transnasal Nicotine in Parkinson Disease Nicotine Nasal Spray 10 MG/ML (0.5 MG/SPRAY) - Parkinson Disease | Phase 2 | Completed | El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez | 6 | 2019-03-04 | 2019-11-06 |
Showing 20 of 48. Sign in to see all of them.
Cognitive Dysfunction (7) · Opioid-Related Disorders (7) · Alzheimer Disease (5) · Prostatic Neoplasms (4) · Substance-Related Disorders (4) · Acquired Immunodeficiency Syndrome (3) · Pain (3) · Stress Disorders, Post-Traumatic (3) · Anxiety Disorders (2) · Breast Neoplasms (2) · Chronic Pain (2) · Dementia (2) · Low Back Pain (2) · Metabolic Syndrome (2) · Obesity (2)
Buprenorphine (2) · Buprenorphine, Naloxone Drug Combination (2) · Meditation (2) · Plyometric Exercise (2) · salicylhydroxamic acid (2) · suvorexant (2) · Adrenergic Agents (1) · Ascorbic Acid (1) · Botulinum Toxins, Type A (1) · Cognitive Behavioral Therapy (1) · Exercise (1) · KB220Z (1) · Maharishi Amrit Kalash (1) · N-(4-((5-(hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolo(1,2-a)pyrimidine-6-carboxamide (1) · Therapeutics (1)
United States (44) · Mexico (1)
Tanya Alim, MD (4) · Charles Nwaokobia (3) · Evaristus Nwulia, MD (3) · Adeyinka O Laiyemo, MD, MPH (2) · Alessio G Morganti, MD (2) · Edwin Chapman, MD (2) · Faye Taxman, PhD (2) · Marc Fishman, MD (2) · William Lawson, MD (2) · Adil Haider, MD, MPH (1) · Andrew Wiznia, MD (1) · Chelsea Kidwell, MD (1) · Christopher Thompson, MS, MD (1) · Denise M. Scott, PhD (1)
PMID 15331239, PMID 17941858, PMID 18835320, PMID 19786427, PMID 20093899, PMID 20211945, PMID 21565525, PMID 21656058, PMID 21785892, PMID 22664645, PMID 23438231, PMID 24051106, PMID 24876243, PMID 25647655, PMID 26107372, PMID 26571023, PMID 27071797, PMID 27094910, PMID 27940700, PMID 28012682, PMID 28359212, PMID 28555708, PMID 28935629, PMID 28960663, PMID 29203084, PMID 29863173, PMID 30038390, PMID 30341154, PMID 30350850, PMID 30567548, PMID 30922315, PMID 31478919, PMID 31535560, PMID 32608505, PMID 34387261, PMID 34942508, PMID 38142149, PMID 39704322, PMID 42311030
P50AT000082 (2), R01DA030768 (2), R44NS125745 (2), U24AT012601 (2), 3UG1DA013034-20 (1), K01MH110647 (1), K23MH126312 (1), P20MD000198 (1), R01AG031517 (1), R01HG002213 (1), R01HL083944 (1), R01MD011685 (1), R44AG061981 (1), R44DA049616 (1), R44DA056156 (1)